Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
John Russel Denton currently holds 174,855 shares of Caris Life Sciences, Inc. (CAI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, John Russel Denton has been a net seller of CAI stock. They have purchased $100.8K and sold $238.6K worth of shares.
John Russel Denton's most recent insider trade was on Sep 22, 2026, when they sold 7,500 shares at $31.82 per share.
John Russel Denton serves as Executive at Caris Life Sciences, Inc. (CAI). They have executed 3 insider transactions totaling $339.4K over their tenure at the company.
John Russel Denton holds the position of Executive at Caris Life Sciences, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 1 years and currently hold a stake valued at $0.
John Russel Denton has shown a selling trading pattern, with $100.8K in total purchases and $238.6K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by John Russel Denton was on Sep 22, 2026, when they sold $238.6K worth of CAI shares. This transaction involved 7,500 shares at $31.82 per share.
John Russel Denton currently owns 174,855 shares of Caris Life Sciences, Inc. (CAI), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of John Russel Denton's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. John Russel Denton has 3 Form 4 filings on record as an insider at Caris Life Sciences, Inc..
Set alerts for John Russel Denton and 40,000+ other insiders.